Cargando…
Regression of fibrous dysplasia in response to denosumab therapy: A report of two cases
We present two patients with fibrous dysplasia who showed a decrease in lesional size and activity after denosumab therapy. Both patients also experienced a reduction in pain and bone turnover markers, which had not been accomplished during previous bisphosphonate therapy. These cases highlight the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066421/ https://www.ncbi.nlm.nih.gov/pubmed/33912627 http://dx.doi.org/10.1016/j.bonr.2021.101058 |